Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

Keyphrases

• Female Patients 100%
• High Risk 100%
• Patient Demographics 100%
• Polycystic Ovary Syndrome 100%
• COVID-19 Pandemic 100%
• COVID-19 100%
• Severe COVID-19 37%
• Cardiometabolic Disease 25%
• Age Groups 12%
• Risk Factors 12%
• Health Care Services 12%
• Health Systems 12%
• Low Risk 12%
• Clinical Practice 12%
• Obesity 12%
• Type 2 Diabetes Mellitus (T2DM) 12%
• Hypertension 12%
• Certain Factor 12%
• High Prevalence 12%
• Potential Risk 12%
• Fast-moving 12%
• Standard of Care 12%
• High Standards 12%
• Complex Patients 12%
• Optimal Management 12%
• Endocrine Disorders 12%
• Women of Reproductive Age 12%
• Sex Group 12%
• Hyperandrogenism 12%
• Low Vitamin D 12%
• COVID-19 Related 12%
• COVID-19 Outbreak 12%
• Hyperinflammation 12%
• Fragmented Care 12%

Medicine and Dentistry

• Patient Population 100%
• Polycystic Ovary Syndrome 100%
• COVID-19 100%
• Disease Predisposition 12%
• Maturity Onset Diabetes of the Young 12%
• Prevalence 12%
• Endocrine Disease 12%
• Hyperandrogenism 12%
• Group Sex 12%
• Vitamin D 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Pandemic 100%
• Ovary Polycystic Disease 100%
• Inflammation 12%
• Prevalence 12%
• Non Insulin Dependent Diabetes Mellitus 12%
• Endocrine Disease 12%
• Disease Predisposition 12%
• Hyperandrogenism 12%
• Vitamin D 12%